Share

    


Home / Search Results

Search Results

You searched for:

    Displaying results 1 - 20 of 30
  • 1
  • 2
  • »
Key findings from three case studies highlight the challenges and triumphs in treating chronic lymphocytic leukemia with oral oncolytics.
The interdisciplinary team at Baptist Health, Miami Cancer Institute evaluated existing processes and leveraged technology to improve oral oncolytic compliance through education, consent, and adherence standards.
Learn about a nurse’s role in care planning, and engaging patients in education, and shared decision making for treatment goals and planning.
In recognition of Pharmacy Technician Day today (October 18), ACCCBuzz spoke with Danielle Duy, CPhT, to learn more about her role on the multidisciplinary cancer care team.
In this episode, our expert describes process improvement strategies to successfully integrate oral oncolytics into practice, and highlights how patient goals can be included in treatment planning.
With the treatment of chronic lymphocytic leukemia (CLL) shifting substantially in the last five years, learn how ACCC is supporting oncology professionals in integrating oral oncolytics in CLL practice.
By turning to technology solutions that are already being used by the health system and that were well understood by their healthcare teams and patients, Baptist Health South Florida, Miami Cancer Institute staff are providing high-quality cancer care without having to dip deeper into its operating budget.
Pharmacy informatics can be leveraged to help clinical inpatient pharmacists ensure the safe use of oral oncolytics during a patient’s hospital stay.
The Elijah E. Cummings Lower Drug Costs Now Act (H.R.3) aims to deliver something a recent poll shows the overwhelming majority of Americans (88 percent) want: lower drug costs.
Because oral anti-cancer agents are most often administered outside of the clinic setting, it takes a multidisciplinary team to successfully manage these patients and their treatments.
The enormous out-of-pocket cost difference between well-covered traditional chemotherapies and often-uncovered oral oncolytics can result in levels of financial toxicity from which many patients struggle to return. To address this issue, the U.S. House of Representatives has this year reintroduced the Cancer Parity Act, which seeks to resolve unequal cost-sharing for oral oncolytics.
St. Luke’s Cancer Institute, formerly known as Mountain States Tumor Institute, established its medically integrated pharmacy in 2010 to manage patients on oral oncolytics. To improve the workflow in the medically integrated pharmacy and assist busy providers with patient care, St. Luke’s Cancer institute’s pharmacy management team discussed opportunities to expand pharmacist responsibilities, including …
In the final installment of ACCC’s webinar series honoring American Pharmacists Month, experts discussed the integral role pharmacists play in supporting clinical trial research in the community setting, and they identified opportunities for extending the pharmacist role in an increasingly complex research landscape.
Recent advances in immuno-oncology (IO) therapies have led to rapid, effective treatments for subsets of patients with cancers that have proven resistant to conventional treatments.
Developing models of care that support older patients with cancer is critical to effectively managing their treatment, improving their outcomes, and promoting their overall quality of care. The second webinar in an online series celebrating American Pharmacists Month, “Older Adults with Cancer: Effective Practices,” examines the role of oncology pharmacists in treating geriatric patients. The Problem …
This blog is the sixth of an eight-post ACCCBuzz series highlighting the achievements of the 2020 ACCC Innovator Award Winners. You can learn more about the innovations being recognized this year and the people who pioneered them by joining us at the ACCC 37th [Virtual] National Oncology Conference, September 14-18. Before 2019, oncology pharmacists at St. Luke’s Cancer Institute’s medically integrated …
To adequately address patient financial toxicity, institutions must assume responsibility for ensuring that patients understand their insurance coverage and anticipated out-of-pocket expenses. Institutions should also have procedures in place to navigate the pre-certification process and prevent claim denials that may ultimately end up as the patient’s responsibility.
The topic of drug waste is nothing new in healthcare. Over the years, reports have surfaced attempting to put a dollar amount on this waste. In 2017, the Centers for Medicaid and Medicare Services began requiring all physicians, hospitals, and other providers submitting Medicare Part B drug claims to report any discarded amount of a single use vial or other single use package drug on its claim for …
Oral oncolytic agents have several advantages over the parenteral route, including patient convenience, prolonged drug exposure, and non-invasive administration.
The cost of prescription drugs is at the forefront of discussions on healthcare reform. At our recent state oncology society meeting, the topic stimulated discussion about medication reuse and recycling programs
    Displaying results 1 - 20 of 30
  • 1
  • 2
  • »